Eli Lilly and Beyond

The Role of International Intellectual Property Treaties in Establishing Legitimate Expectations in Investor-State Dispute Settlement
Nomos, 1. Edition 2018, 84 Pages
The product is part of the series Munich Intellectual Property Law Center – MIPLC
Book
€24.00
ISBN 978-3-8487-5109-9
Temporarily unavailable. Delivery delay approximately 14 days
eBook
€0.00
ISBN 978-3-8452-9311-0
Available
Prices include VAT. Depending on the delivery address, VAT may vary at checkout.
Description
Through the emergence of several high-profile investment arbitration cases, the effects of IPRs as investments covered under IIAs have finally come to light. The latest award, the only arbitration case dealing with patents as IPRs – the Eli Lilly v. Canada case – has brought up a number of interesting questions. Two of Eli Lilly's patents have been revoked, whereupon the company tried to redeem them through investment arbitration. One of the claims put forward by Eli Lilly is that his legitimate expectations, a standard of protection found in international investment law, have been frustrated by Canada. By allegedly failing to observe its obligations contained in Chapter 17 of the NAFTA, Canada frustrated the legitimate expectations of Eli Lilly. The thesis tries to analyze how the relationship between international IP treaties and legitimate expectations functions.
Bibliographical data
Bibliographical data
Edition 1
ISBN 978-3-8487-5109-9
Subtitle The Role of International Intellectual Property Treaties in Establishing Legitimate Expectations in Investor-State Dispute Settlement
Publication Date Jul 20, 2018
Year of Publication 2018
Publisher Nomos
Format Softcover
Language englisch
Pages 84
Medium Book
Product Type Scientific literature
Product safety information

Manufacturer of products offered under GPSR

Nomos Verlagsgesellschaft mbH & Co. KG
Waldseestraße 3 - 5
76530 Baden-Baden, Germany

service@nomos.de
www.nomos.de

© 2025 Nomos Verlagsgesellschaft mbH & Co. KG